Skip to main content
Premium Trial:

Request an Annual Quote

Where Are They Now?: Sep 1, 2003

Premium

Last year’s issue of Genome Technology took you inside the new Arizona cancer genomics initiative called the International Genomics Consortium. Since then, the IGC has continued to gain momentum. In March it named Michael Berens CEO, and Robert Penny as chief medical officer. And by June, the consortium heralded the groundbreaking of its home-to-be in downtown Phoenix. The $46 million facility, also occupied by the Translational Genomics Research Institute, is expected to be open in November of next year.

The September ’02 issue also looked at the upcoming merger of Pfizer and Pharmacia. That deal closed in April, and the acquisition helped Pfizer’s Discovery Technology Center (see p. 19).

GT also checked in on compensation packages for genomics execs, listing some of the stranger perks used to lure people to different companies. In the year since, the magazine launched the industry’s first genomics salary survey, finding that the median salary range is currently $75,000 to $99,000.

Finally, IT Guy Nat Goodman gave you his second back-to-school feature, a roundup of online courses. This year, Nat pursues the same theme and looks at the lousy bioinformatics job market and what bioinformaticists need to do to keep themselves relevant (see p. 36).

 

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.